RecruitingPhase 2NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Sponsor: AbbVie
Dothan, AL · Phoenix, AZ · Sun City, AZ · +57 more sites
Phase 2 Ulcerative Colitis clinical trials
23 recruiting Phase 2 ulcerative colitis studies in the US. What trial phases mean
Other phases
RecruitingPhase 2NCT07186101
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Sponsor: Eli Lilly and Company
Scottsdale, AZ · Anaheim, CA · Lancaster, CA · +37 more sites
RecruitingPhase 2NCT07415044
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Sponsor: Eli Lilly and Company
Phoenix, AZ · Scottsdale, AZ · Anaheim, CA · +49 more sites
RecruitingPhase 2NCT07483073
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Sponsor: Eli Lilly and Company
Scottsdale, AZ · Los Angeles, CA · Oxnard, CA · +11 more sites
RecruitingPhase 2NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Sponsor: Spyre Therapeutics, Inc.
Canoga Park, CA · La Jolla, CA · Lancaster, CA · +23 more sites
RecruitingPhase 2NCT07501078
Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation
Sponsor: Muhammad N Aslam, MD
Ann Arbor, MI
RecruitingPhase 2NCT07296315
Confirmatory Clinical Study in Active Ulcerative Colitis
Sponsor: MRM Health NV
Miami, FL · Orlando, FL · Palmetto Bay, FL · +3 more sites
RecruitingPhase 2NCT07845487
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Palisade Bio
Sun City, AZ · San Diego, CA · Bristol, CT · +27 more sites
RecruitingPhase 2NCT06979336
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Sponsor: Genentech, Inc.
Lancaster, CA · San Diego, CA · Colorado Springs, CO · +5 more sites
RecruitingPhase 2NCT07463183
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Sponsor: Merck Sharp & Dohme LLC
Anaheim, CA · Coronado, CA · Colorado Springs, CO · +8 more sites
RecruitingPhase 2NCT07513181
Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Sponsor: Athos Therapeutics Inc
Miami, FL · Tampa, FL · Roswell, GA · +1 more sites
RecruitingPhase 2NCT07470879
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Sponsor: Pfizer
New York, NY · +4 more sites
RecruitingPhase 2NCT06636656
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Sponsor: Boehringer Ingelheim
Scottsdale, AZ · Colorado Springs, CO · Kissimmee, FL · +11 more sites
RecruitingPhase 2NCT06420375
Treatment of UC With Novel Therapeutics
Sponsor: Brigham and Women's Hospital
Chestnut Hill, MA
RecruitingPhase 2NCT05287126
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Sponsor: Pfizer
Little Rock, AR · Garden Grove, CA · +17 more sites
RecruitingPhase 2NCT05218850
The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
Sponsor: Children's Hospital Los Angeles
Los Angeles, CA
RecruitingPhase 2NCT06764615
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Sponsor: Takeda
Glen Burnie, MD · Tyler, TX
RecruitingPhase 2NCT07427017
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
Sponsor: Northwestern University
Chicago, IL
RecruitingPhase 2NCT07223424
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
Sponsor: Diwakar Davar
Pittsburgh, PA
RecruitingPhase 2NCT07113522
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Sponsor: Mirador Therapeutics, Inc.
Birmingham, AL · Scottsdale, AZ · Sun City, AZ · +43 more sites
RecruitingPhase 2NCT04373473
Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis
Sponsor: The University of Texas Health Science Center, Houston
Houston, TX
RecruitingPhase 2NCT06420492
Study of Novel Therapeutics for Acute Remedy of Colitis
Sponsor: Brigham and Women's Hospital
Chestnut Hill, MA
RecruitingPhase 2NCT04721873
Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients
Sponsor: University of California, San Diego
La Jolla, CA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.